Business Daily from THE HINDU group of publications
Tuesday, Jul 11, 2006
Business Daily from THE HINDU group of publications Tuesday, Jul 11, 2006 |
|
|
|
|
|
|
|
Corporate
-
Outlook JB Chem intensifies focus on 3 segments Our Bureau
Mumbai , July 10 The Mumbai-based drug company JB Chemicals and Pharmaceuticals Ltd has intensified its focus on cardiology, orthopaedics and gastroenterology, to improve the "prescription strike-rate" of medicines in these segments. It has shored-up its marketing muscle by adding 180 people dedicated to marketing drugs in these three segments. This would be increased in time to about 225 people, a company official said. JB Chem's total marketing fleet would increase to about 625, a note from the company said. By having a specialised team of medical representatives, the doctor-detailing would be improved. This would, in turn, improve the rate at which such meetings translate into doctors actually prescribing the drug, a company official told Business Line. The company has launched a new speciality division to primarily focus on these three therapeutic segments and JB Chem has already launched premium products in these segments. The company will promote and market its brands through its own marketing team using its strength in these core areas, the company said. The total market size of cardiology, orthopaedic and gastroentrology is estimated at Rs 2,900 crore, growing by more than 16 per cent per annum, the company note said. JB Chem's shares were down 1.13 per cent at Rs 91.50 on the BSE.
More Stories on : Outlook | Health | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|